Hsa_circ_0000437 Inhibits the Development of Endometrial Carcinoma through miR-626/CDKN1B Axis

Xiaojuan Li1, Yahong Liu1

  • 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China.

Abstract

Insights

Circular RNA hsa_circ_0000437 (circ_0000437) suppresses endometrial carcinoma progression by regulating the miR-626/CDKN1B pathway. Low circ_0000437 levels correlate with advanced disease, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) play a significant role in cancer biology.
  • The specific functions of circular RNA hsa_circ_0000437 (circ_0000437) in endometrial carcinoma (EC) remain largely unknown.
  • This study investigates the expression and functional role of circ_0000437 in EC progression.

Purpose of the Study:

  • To determine the expression patterns of circ_0000437 in EC tissues and cells.
  • To elucidate the role of circ_0000437 in EC cell proliferation, invasion, and epithelial-mesenchymal transition (EMT).
  • To uncover the underlying molecular mechanisms involving circ_0000437, microRNA-626 (miR-626), and cyclin-dependent kinase inhibitor 1B (CDKN1B) in EC.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression analysis.
  • Cellular assays including EdU, CCK-8, and Transwell assays to assess proliferation and invasion.
  • Western blot to detect protein expression of CDKN1B and EMT markers.
  • Dual-luciferase reporter and RNA immunoprecipitation (RIP) assays to confirm molecular interactions.

Main Results:

  • circ_0000437 expression was significantly reduced in EC tissues and correlated with lymph node metastasis and advanced TNM stage.
  • Knockdown of circ_0000437 promoted EC cell proliferation, invasion, and EMT.
  • circ_0000437 directly targets miR-626, negatively regulating its expression, and miR-626 targets CDKN1B.

Conclusions:

  • circ_0000437 functions as a tumor suppressor in EC by modulating the miR-626/CDKN1B pathway.
  • circ_0000437 inhibits EC cell proliferation, invasion, and EMT.
  • circ_0000437 holds promise as a potential biomarker and therapeutic target for endometrial carcinoma.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K